About Enrique Carrazana
Enrique Carrazana is a board director at CND Life Sciences.
Enrique Carrazana first appears on SEC filings in 2021.
Experience
This experience comes from Enrique Carrazana's profile and from SEC filings. For roles taken from filings, the years are when the filings name Enrique Carrazana in the role, so the role may have started earlier or lasted longer.
CND Life Sciences, Inc. Current
Director, Board Of Directors
2021 – Present · Scottsdale, AZ
Skin biopsy testing helps clinicians assess patients for Parkinson’s disease and related disorders.
NI
Neurelis, Inc. Current
SVP - Strategic Initiatives
2016 – Present
HI
Hawaii Biotech, Inc.
Director - Board Of Directors
2018 – 2025
MP
Marinus Pharma
Director - Board Of Directors
2013 – 2021
AT
Acorda Therapeutics
Chief Medical Officer
2011 – 2016
UM
University of Miami
Epilepsy Division (2010 – 2011)
Associate Professor, Neurology; Director of VAH Epilepsy Center of Excellence (2010 – 2011)
2010 – 2011
NA
Novartis Pharma AG
Global Head, Established Medicines Development Franchise
2001 – 2010
Key Colleagues at Startups
The people Enrique Carrazana works with at each company, as listed on that company's latest Form D.
CND Life Sciences, Inc. · Form D/A, Aug 3, 2026
Richard Morello
Chief Executive Officer and director
Christopher Gibbons
Chief Scientific Officer, Co-Founder and director
Peter Harris
Board Chair
Jack Seaver
Board Director
Todd Levine
Chief Medical Officer, Co-Founder and director